Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review in: European Journal of Endocrinology Volume 181 Issue 3 (2019)
![PDF] Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c9945a3148c79f31d8a56b4b1eb4d2b6d1d0c246/5-Table4-1.png "PDF] Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review | Semantic Scholar")
PDF] Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review | Semantic Scholar
Frontiers | Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
Clinical characteristics and human leukocyte antigens in patients with immune checkpoint inhibitor-induced type 1 diabetes and pituitary dysfunction: a single center prospective study | SpringerLink
The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint Inhibitors (11.06.2021)
Type 1 diabetes related to immune checkpoint inhibitors - ScienceDirect
Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome - The Lancet Diabetes & Endocrinology
Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune Diabetes: Trends in Molecular Medicine
Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus? | RCP Journals
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes - Quandt - 2020 - Clinical & Experimental Immunology - Wiley Online Library
Imaging the Inflammatory Response in Checkpoint Inhibition Myocarditis | Journal of Nuclear Medicine
Cancers | Free Full-Text | Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario
Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports.
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes - Quandt - 2020 - Clinical & Experimental Immunology - Wiley Online Library
Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes | BMJ Open Diabetes Research & Care
Frontiers | Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
IJMS | Free Full-Text | Immune Checkpoint Inhibitor-Induced Diabetes Mellitus: Potential Role of T Cells in the Underlying Mechanism
Diabetic ketoacidosis following immunotherapy for lung cancer | Tidsskrift for Den norske legeforening
Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies | Nature Reviews Drug Discovery
Different forms of diabetes mellitus induced by checkpoint inhibitors.... | Download Scientific Diagram
Endocrine complications of immunotherapies: a review | RCP Journals
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review in: European Journal of Endocrinology Volume 181 Issue 3 (2019)
Proposed Pathogenesis of Checkpoint Inhibitor Associated Autoimmune... | Download Scientific Diagram
Frontiers | Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
